Australia's most trusted
source of pharma news
Wednesday, 18 February 2026
Posted 18 February 2026 AM
Roche has tapped Peter MacCallum Cancer Centre haematologist Professor Mark Dawson for the role of Head of Pharma Research and Early Development (pRED) starting in May.
Dawson, who has been with Peter Mac since 2014 as Associate Director of Research will relocate to Basel for the job. He will also join the company's enlarged Corporate Executive Committee.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.